Literature DB >> 32240022

Central AT1 receptor signaling by circulating angiotensin II is permissive to acute intermittent hypoxia-induced sympathetic neuroplasticity.

Caroline G Shimoura1, Mary Ann Andrade1, Glenn M Toney1,2.   

Abstract

Acute intermittent hypoxia (AIH) triggers sympathetic long-term facilitation (sLTF), a progressive increase in sympathetic nerve activity (SNA) linked to central AT1 receptor (AT1R) activation by circulating angiotensin II (ANG II). Here, we investigated AIH activation of the peripheral renin-angiotensin system (RAS) and the extent to which the magnitude of RAS activation predicts the magnitude of AIH-induced sLTF. In anesthetized male Sprague-Dawley rats, plasma renin activity (PRA) increased in a linear fashion in response to 5 (P = 0.0342) and 10 (P < 0.0001) cycles of AIH, with PRA remaining at the 10th cycle level 1 h later, a period over which SNA progressively increased. On average, SNA ramping began at the AIH cycle 4.6 ± 0.9 (n = 12) and was similar in magnitude 1 h later whether AIH consisted of 5 or 10 cycles (n = 6/group). Necessity of central AT1R in post-AIH sLTF was affirmed by intracerebroventricular (icv) losartan (40 nmol, 2 µL; n = 5), which strongly attenuated both splanchnic (P = 0.0469) and renal (P = 0.0018) sLTF compared with vehicle [artificial cerebrospinal fluid (aCSF), 2 µL; n = 5]. Bilateral nephrectomy largely prevented sLTF, affirming the necessity of peripheral RAS activation. Sufficiency of central ANG II signaling was assessed in nephrectomized rats. Whereas ICV ANG II (0.5 ng/0.5 µL, 30 min) in nephrectomized rats exposed to sham AIH (n = 4) failed to cause SNA ramping, it rescued sLTF in nephrectomized rats exposed to five cycles of AIH [splanchnic SNA (SSNA), P = 0.0227; renal SNA (RSNA), P = 0.0390; n = 5]. Findings indicate that AIH causes progressive peripheral RAS activation, which stimulates an apparent threshold level of central AT1R signaling that plays a permissive role in triggering sLTF.NEW & NOTEWORTHY Acute intermittent hypoxia (AIH) triggers sympathetic long-term facilitation (sLTF) that relies on peripheral renin-angiotensin system (RAS) activation. Here, increasing AIH cycles from 5 to 10 proportionally increased RAS activity, but not the magnitude of post-AIH sLTF. Brain angiotensin II (ANG II) receptor blockade and nephrectomy each largely prevented sLTF, whereas central ANG II rescued it following nephrectomy. Peripheral RAS activation by AIH induces time-dependent neuroplasticity at an apparent central ANG II signaling threshold, triggering a stereotyped sLTF response.

Entities:  

Keywords:  hypertension; sleep apnea; sympathetic nerve activity; synaptic plasticity

Mesh:

Substances:

Year:  2020        PMID: 32240022      PMCID: PMC7272754          DOI: 10.1152/japplphysiol.00094.2020

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  53 in total

Review 1.  Expressions of angiotensin and cytokine receptors in the paracrine signaling of the carotid body in hypoxia and sleep apnea.

Authors:  Man Lung Fung
Journal:  Respir Physiol Neurobiol       Date:  2014-10-03       Impact factor: 1.931

2.  Effects of intermittent hypoxia on sympathetic activity and blood pressure in humans.

Authors:  Urs A Leuenberger; Derick Brubaker; Sadeq A Quraishi; Sadeq Quraishi; Cynthia S Hogeman; Virginia A Imadojemu; Kristen S Gray
Journal:  Auton Neurosci       Date:  2005-08-31       Impact factor: 3.145

3.  Selected contribution: Time-dependent hypoxic respiratory responses in female rats are influenced by age and by the estrus cycle.

Authors:  A G Zabka; M Behan; G S Mitchell
Journal:  J Appl Physiol (1985)       Date:  2001-12

4.  Menstrual cycle and sex effects on sympathetic responses to acute chemoreflex stress.

Authors:  Charlotte W Usselman; Tamara I Gimon; Chantelle A Nielson; Torri A Luchyshyn; Nicole S Coverdale; Stan H M Van Uum; J Kevin Shoemaker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-19       Impact factor: 4.733

5.  Acute intermittent hypoxia in rat in vivo elicits a robust increase in tonic sympathetic nerve activity that is independent of respiratory drive.

Authors:  Tao Xing; Paul M Pilowsky
Journal:  J Physiol       Date:  2010-06-21       Impact factor: 5.182

6.  Activation of the hypothalamic paraventricular nucleus by forebrain hypertonicity selectively increases tonic vasomotor sympathetic nerve activity.

Authors:  Walter W Holbein; Glenn M Toney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-12-17       Impact factor: 3.619

7.  Hypophysiotropic thyrotropin-releasing hormone and corticotropin-releasing hormone neurons of the rat contain vesicular glutamate transporter-2.

Authors:  Erik Hrabovszky; Gábor Wittmann; Gergely F Turi; Zsolt Liposits; Csaba Fekete
Journal:  Endocrinology       Date:  2004-10-14       Impact factor: 4.736

8.  Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat.

Authors:  P E Sawchenko; L W Swanson; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Chronic intermittent hypoxia sensitizes acute hypothalamic-pituitary-adrenal stress reactivity and Fos induction in the rat locus coeruleus in response to subsequent immobilization stress.

Authors:  S Ma; S W Mifflin; J T Cunningham; D A Morilak
Journal:  Neuroscience       Date:  2008-05-06       Impact factor: 3.590

10.  Carotid body potentiation during chronic intermittent hypoxia: implication for hypertension.

Authors:  Rodrigo Del Rio; Esteban A Moya; Rodrigo Iturriaga
Journal:  Front Physiol       Date:  2014-11-12       Impact factor: 4.566

View more
  1 in total

1.  Local ionotropic glutamate receptors are required to trigger and sustain ramping of sympathetic nerve activity by hypothalamic paraventricular nucleus TNFα.

Authors:  Aline A Mourão; Caroline G Shimoura; Mary Ann Andrade; Tamara T Truong; Gustavo R Pedrino; Glenn M Toney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-08-06       Impact factor: 5.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.